There are no reviews yet. Be the first to send feedback to the community and the maintainers!
Covid19CharacterizationCharybdis
Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2 (CHARYBDIS) - a study to describe the baseline demographic, clinical characteristics, treatments and outcomes of interest among individuals tested for SARS-CoV-2 and/or diagnosed with COVID-19 compared to Influenza patients from 2017-2018LegendT2dm
Covid19PredictionStudies
Development and validation OHDSI network studies for the covid19 prediction topicHERACharacterization
Health equity research assessment (HERA) - a large scale characterization of gender and racial disparitiesMentalHealthEquity
Assessing Health Equity in Mental Healthcare Delivery Using a Federated Network Research ModelCovid19HospitalizationCharacterization
Clinical Characterization of COVID-19PioneerWatchfulWaiting
This study is part of the joint PIONEER - EHDEN - OHDSI studyathon in March 2021, and aims to advance understanding of clinical management and outcomes of watchful waiting in prostate cancer.MethodsLibraryPleEvaluation
R code used to evaluate the OHDSI Methods Library for population-level estimationCovid19EstimationHydroxychloroquine
Retrospective, real-world, observational study to estimate the population-level effects of hydroxychloroquine among patients with rheumatoid arthritis. Designed and executed during the OHDSI community COVID-19 virtual study-a-thon (March 26-29) to inform healthcare decision-making in response to the current global pandemic.HowOften
[under development] Large-scale incidence characterizationDeepLearningComparison
Investigating different deep learning approachesStudyRepoTemplate
A template for new study repositoriesRanitidineCancerRisk
RanitidineCancerRiskCervello
Covid-19 pandEmic impacts on mental health Related conditions Via multi-database nEtwork: a LongitutinaL Observational study (CERVELLO)BipolarMisclassificationValidation
OHDSI network study: external validation of a simple score model that predicts whether patients newly diagnosed with MDD actually have bipolarAntiVegfKidneyFailure
BreastCancerBetweenScreen
WOO 2019 study: Predicting breast cancer within 3 years of a negative mammographyPCE
Network study validating the Pooled Cohort Equation ModelConceptPrevalence
A package to calculate the counts of the standard and source concepts in an OMOP CDM and extract the current version of the mappings used.Covid19Icarius
Real-world, observational study to estimate the population-level effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complicationsEvaluatingCardinalityMatching
This study aims to evaluate the performance of cardinality matching and large-scale propensity score matching at progressively smaller sample sizes and more stringent parameter settings among new users of ACEI vs. thiazide or thiazide-like diuretic monotherapy applying the framework set forth in the LEGEND-HTN study.PhenotypePhebruaryCapr
Repo to store Capr implementations of all cohort definitions created during Phenotype PhebruaryDeadModel
A package for implementing the death imputation model on OMOP CDM dataPsmVsCm
Indirect covariate balance and residual confounding: an applied comparison of propensity score matching and cardinality matchingHIVTreatmentPathways
Corazon
Covid19SubjectsAesiIncidenceRate
Extending on our previous work by Li et al. in understanding the incidence rates of adverse events of special interest (AESI) for COVID-19, this work will look at the rates of these AESIs in patients who had COVDI-19 disease.dGEMcovid
ScyllaCharacterization
The aim of this study is to characterize all emerging drug therapies used in COVID-19 treatment.cmcEndoPcos
Study specifications from the DBMI/OHDSI/JNJ Study-a-thon on Women's Health.MyositisNetworkStudy
OHDSI Network Study lead by John Hopkins Myositis GroupDistributedLMM
A distributed method for calculating pooled effect estimates applied to COVID-19 hospitalizationPORPOISE
PORPOISE research code and materials for training and validating ML models on the network of OMOP CDM databases.EhdenCovidUseCase
The aim of this study is to estimate treatment effects for COVID-19 treatments using data from the EHDEN network and to combine these observational results with data from randomised studies.MusculoskeletalAEsAfterAIs
A Population level estimate (PLE) cohort study with prior A Cohort Diagnostics study to determine the feasibility using non-identifiable data mapped to the OHDSI Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to evaluate the risk of adverse musculoskeletal events in post-menopausal women taking AI compared to tamoxifen to treat breast cancer.EhdenRaDrugUtilization
Rheumatoid arthritis drug utilization (Barcelona Study-a-thon 2020)NLP-Oncology
[under development] Redoing Karthik's cancer pathways study with and without NLP-derived histology data (mapped to cancer teminologies)SemaglutideNaion
OHDSI network study for population-level effect estimation of risk of NAION and other vision disorders from exposure to semaglutide.Eumaeus
Evaluating Use of Methods for Adverse Event Under Surveillance (for vaccines)CovidSeverityPrediction
The algorithm to predict mortality and severe clinical outcome in patients with COVID-19Ceeamos
OHDSI study to investigate the risk of schizophrenia in hypertensive patients using ACE inhibitorGlp1ClrdEstimation
PhenotypePhebruary
EhdenRaPrediction
Prediction of clinical outcomes after methotrexate initiationDMCharacterizationAP
TicagrelorVsClopidogrel
OHDSI network study: Net Adverse Clinical Event between Ticagrelor and Clopidogrel in Patients with Acute Coronary SyndromeCovid19CohortEvaluation
A central package for evaluation the cohorts used in the various Covid-19 studiesPhenotypeLibraryDiagnostics
Computing cohort diagnostics for all cohort definitions in the OHDSI Phenotype LibraryFluoroquinoloneAorticAneurysm
[under development]MddAfterBbValidation
Covid19VaccinePrediction
A methodology study into the stability of prediction models across target cohort and outcome phenotypesCovid19VaccineAesiDiagnostics
Covid19VaccineAesiIncidenceRate
Medon
Methods Evaluation of Durability in a Observational Network (MEDON).VaccineEffectivenessEvaluation
Covid19DrugRepurposing
Evaluation of the safety (and where possible efficacy) of existing drugs considered for treatment of COVID-19.ExistingStrokeRiskExternalValidation
A package for validating some previously published stroke modelsCOVID19CancerBaselineCharacterization
Future OHDSI network study to understand the baseline characteristics of cancer patients with COVID-19OutcomeMisclassificationSysRev
Systematic review of outcome misclassification correction in pharmacoepidemiologyCauseSpecificMortality
Development of cause of death predictive model using Patient-level predictionLegendT2dmEvidenceExplorer
LEGEND-T2DM Evidence ExplorerCovid19SusceptibilityAlphaBlockers
PandemicPrediction
Validating the COVID prediction models across time and databasesPceCohortDiagnostics
OT2DSI
Observational study of type 2 diabetes and its complications: a chronological overview using the OHDSI networkMultipleSclerosisBiologicsPml
[under development]FeatureSelectionComparison
PatientLevelPrediction methods research investigating different feature selection approaches for simplifying modelsEmptyStudyRepository
An empty repository, to be used as the template for new studiesEhdenRaDmardsEstimation
Retrospective, real-world, observational study to estimate the population-level effects of conventional synthetic disease-modifying antirheumatic drugs among patients with rheumatoid arthritis. Designed and executed at the EHDEN Study-a-thon in Barcelona, January 2020.ScyllaEstimation
This OHDSI network study assesses the comparative effectiveness and safety among treatments administered during hospitalization and prior to intensive services. It also assesses the comparative effectiveness and safety among treatments administered after COVID-19 positive testing or diagnosis in the outpatient setting without prior hospitalization.ReproducibilityRayJAMA2021
Reproducibility study of Ray et al JAMA 2021 comparative effectiveness of rivaroxaban vs apixaban in atrial fibrillationCancerTxPathway
A package to extract chemotherapy records for cancer patients. The chemotherapy records are instantiated as Episode / Episode Event table with corresponding regimen as episode source concept id. The package also portrait the treatment patterns for patients with cancer and onset timing of the adverse event, i.e., neutropenia.Covid19EstimationHydroxychloroquine2
Retrospective, real-world, observational study to estimate the population-level effects of hydroxychloroquine among patients with rheumatoid arthritis on select psychiatric and influenza outcomes. Designed during the OHDSI community COVID-19 virtual study-a-thon (March 26-29) to inform healthcare decision-making in response to the current global pandemic.Love Open Source and this site? Check out how you can help us